Mercy Medical System first in New York to install clinical LumaGEM MBI system

Jodelle Maglaya | | Health Imaging | Womens Imaging

Gamma Medica announced that New York’s first clinical LumaGEM Molecular Breast Imaging (MBI) system has been installed at Mercy Center, a member of Catholic Health Services of Long Island.

MBI is a secondary screening and diagnostic tool used for women who have dense breast tissue and those at risk of being diagnosed with cancer.

“We are thrilled to partner with the Mercy Medical Center to provide the women of New York access to state-of-the-art MBI technology,” said Philip Croxford, Gamma Medica president and CEO in a statement.

“This is just the latest milestone in Mercy’s longstanding dedication to the fight against cancer,” said Mercy’s Executive Vice President and Chief Administration Officer Ron Steimel.

According to a study published in the American Journal of Roentgenology, MBI increases early detection in women who are at high risk of being diagnosed with cancer, due to dense breast tissue. In the retrospective clinical study published, MBI was able to detect 7.7 cancers per 1,000 women screened that were not found using mammography. 

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

How radiologists can help identify victims of domestic violence
New low-field scanner detects cancer spread better than traditional breast MRI
New FDA-cleared algorithm could improve fetal anomaly detection on ultrasound
MRI technique makes breast cancer 'glow' on imaging
Commercially insured women less likely to be referred for interventional procedures
Deep learning reconstruction cuts breast MRI scan times in half

Around the web

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.